News
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ('Kelun-Biotech', 6990.HK) today announced that results from its ...
14h
AZoLifeSciences on MSNZebrafish model for an ultra-rare genetic disease identifies potential treatmentsXMEA is a recessive, genetic disease that causes progressive muscle weakness. Can a small fish help identify possible ...
2d
GlobalData on MSNIambic concludes dose escalation in Phase I/Ib trial of IAM1363US-based Iambic Therapeutics has concluded the dose escalation phase in its multi-centre Phase I/Ib trial of a ...
Find out Megan Fox’s top films, highlighting her diverse roles from action-packed blockbusters to gripping thrillers. Read on to know more!
Can a small fish help identify possible treatments for an ultra-rare inherited disease found in an Alabama boy? The genetic ...
Ultimate X-Men #16 hits stores Wednesday! Springtime brings new beginnings in Hi No Kuni, but Hisako's dark influence grows.
Teenage Mutant Ninja Turtles co-creator Kevin Eastman sat down with Newsweek to discuss how the turtles have exceeded ...
4d
Screen Rant on MSNWait, Did X-Men Just Quietly Reboot Its Most Powerful Mutant?The Marvel Universe’s most powerful mutant is about to make a major comeback, finally taking center stage as the X-Men’s ...
Using a simple zebrafish model of the ultra-rare genetic disease XMEA, researchers were able to test 30 clinically tested ...
James A. Castillo's 'The Quinta’s Ghost,' debuting at Tribeca, explores Goya's art and trauma, blending horror and Spanish ...
Among the 43 evaluable patients treated with sevabertinib, the confirmed objective response rate was 72.1%.
Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results